- Home
- VSTA vs CRVS Comparison
VSTA vs CRVS Comparison
Compare VSTA & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTA
- CRVS
- Stock Information
- Founded
- VSTA 1966
- CRVS 2014
- Country
- VSTA Brazil
- CRVS United States
- Employees
- VSTA N/A
- CRVS N/A
- Industry
- VSTA Other Consumer Services
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- VSTA Real Estate
- CRVS Health Care
- Exchange
- VSTA Nasdaq
- CRVS Nasdaq
- Market Cap
- VSTA 332.9M
- CRVS 305.4M
- IPO Year
- VSTA 2020
- CRVS 2016
- Fundamental
- Price
- VSTA $4.10
- CRVS $4.67
- Analyst Decision
- VSTA Sell
- CRVS Strong Buy
- Analyst Count
- VSTA 1
- CRVS 4
- Target Price
- VSTA N/A
- CRVS $15.00
- AVG Volume (30 Days)
- VSTA 12.0K
- CRVS 930.7K
- Earning Date
- VSTA 08-06-2025
- CRVS 08-05-2025
- Dividend Yield
- VSTA N/A
- CRVS N/A
- EPS Growth
- VSTA N/A
- CRVS N/A
- EPS
- VSTA 1.00
- CRVS N/A
- Revenue
- VSTA $286,712,653.00
- CRVS N/A
- Revenue This Year
- VSTA $14.62
- CRVS N/A
- Revenue Next Year
- VSTA $10.84
- CRVS N/A
- P/E Ratio
- VSTA $4.05
- CRVS N/A
- Revenue Growth
- VSTA 6.46
- CRVS N/A
- 52 Week Low
- VSTA $1.60
- CRVS $2.13
- 52 Week High
- VSTA $5.49
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- VSTA 44.83
- CRVS 63.43
- Support Level
- VSTA $3.92
- CRVS $4.10
- Resistance Level
- VSTA $4.19
- CRVS $4.38
- Average True Range (ATR)
- VSTA 0.14
- CRVS 0.20
- MACD
- VSTA -0.01
- CRVS 0.04
- Stochastic Oscillator
- VSTA 53.33
- CRVS 93.97
About VSTA Vasta Platform Limited
Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).